IDS history began in 1957, when chairman Teruaki Itoh founded an electrical engineering company that steadily expanded into the development of custom industrial machines and automation systems. In the late 1970s, the company transformed its expertise into pioneering laboratory automation systems, which laid the foundation for its global role in open automation solutions.
Itoh Denki Seisakusho, (伊藤電機製作所), was established as a specialized electrical and machinery workshop in Kumamoto.
From the outset, the company focused on custom-built electrical systems, control panels, and factory automation related equipment for public infrastructure, commercial facilities, and industrial clients.
During a period when imported systems dominated the market, Itoh Denki Seisakusho (伊藤電機製作所) distinguished itself by developing high-quality domestic alternatives through independent engineering expertise. The company quickly expanded its work to support major Japanese corporations such as Mitsui & Co. and Asahi Kasei.
President Teruaki Itoh was featured in a Japanese publication, where he expressed,
“We must never produce anything inferior, and we must never create problems for our customers.”
More than five decades later, that commitment to engineering excellence and customer responsibility remains at the core of IDS.
Reproduced for historical reference. Original publication: Sunday Graphic, August 1974. Copyright remains with the original publisher.
In 1975, Itoh Denki Seisakusho, was entrusted with the maintenance of AutoChemist automated analyzers. At the time, such systems were large and highly complex, requiring deep technical expertise to operate and sustain. Taking on this engagement from a major healthcare conglomerate that served as the silent engine behind Japan’s clinical testing industry, became a defining moment for Itoh Denki Seisakusho. This moment steered the company toward laboratory automation services and establishing an enduring commitment to product improvement and original system development.
In 1981, Itoh further advanced his automatic tube decapper concept, aiming to introduce safer, contact-free sample handling to the U.S. market. At the time, many hospitals had not yet recognized the need for such automation as labour was readily available despite lack of safety.
While the technology was ahead of its time, the experience strengthened Ito’s conviction that laboratory automation and safety would soon become essential.
Itoh Denki Seisakusho, signed a joint development contract with a major Japanese trading and investment group to deliver 20 units of a Medical Electronic (ME) device interface for a national medical research institute.
The device functioned as a computer interface linking blood analysis and electrocardiogram inspection equipment, enabling the centralized storage of test results.
Itoh Denki Seisakusho, developed an automatic test tube decapper as a market-ready product, capable of sensing a loaded test tube and automatically removing the cap. Eliminating the need for repeated button operation by laboratory staff. This was a breakthrough for a equipment to allow a laboratory staff to walk away to manage other task.
Following its development, the system was manufactured and supplied over a multi-year period in response to orders received through the same Japanese major global trading and investment conglomerate.
In July 1984, Itoh Denshi (Itoh Electronics Co., Ltd.), 伊藤電子, was established as a subsidiary to support expanding electronics and automation system development activities.
Itoh developed a prototype aliquoting system capable of automatically dividing blood samples into multiple secondary tubes based on test requirements. The system was recognized under the Technical Improvement Subsidy program of Japan’s Ministry of International Trade and Industry (MITI), validating its technical originality and innovation.
The technology was later introduced in the United States by a professor from Kurume University School of Medicine, increasing awareness of Itoh’s work among overseas laboratories. Around the same time, an interest by Shimane Medical University supported the development of a custom integrated system in collaboration with the university’s laboratory team.
An automatic sorting and dispensing system capable of handling various sample tube types, with a throughput of up to 1,000 blood samples per hour, was jointly developed with a major Japanese trading conglomerate.
The first completed unit was delivered to a healthcare organization in Kasuga City, Fukuoka Prefecture, in late 1986.
A new stand-alone company, Itoh Denshi (Itoh Electronics), 伊藤電子, was established to focus exclusively on medical automation manufacturing. Separating the group’s other electrical manufacturing operations.
Through an already established relationship with a Kobe-based company that was engaged in research, manufacture, and sale of specimen testing reagents, Itoh Denshi exhibited its technology at a major medical trade show in Florida, USA.
This marked Itoh Denshi’s first major international presentation of its laboratory automation concepts which further sharpened its understanding of real-world laboratory needs.
Itoh Denshi completed and installed its first fully integrated pre-analytical sample transport system, later known as TLA-100 at the Shimane Medical University.
Key milestones
Following this breakthrough, the company was renamed IDS.
IDS’s open and modular specimen transport system gained U.S. attention through its deployment at Shimane Medical University, where it was connected to Coulter analyzers and demonstrated interoperability with third-party analyzers.
This led to multiple visits by laboratory partners and Coulter representatives to Kumamoto for technical discussions, on-site inspections, and continued exchange of ideas and laboratory needs.
IDS entered into an agreement with Coulter Corporation, leading to collaborative efforts in developing custom automation solutions tailored to the needs of laboratories worldwide.
From 1994 onward, IDS expanded its role in OEM manufacturing and deployment of laboratory automation systems worldwide, collaborating with IVD partners to address specialized operational needs.
During this period, systematic expansion of our nationwide office network also ensured comprehensive service coverage and localized support across Japan while achieving rapid growth in market share within the domestic market and neighboring regions, including South Korea.
IDS concluded a contract research agreement on sample transport systems with the University of Tokyo.
IDS continues to expand its production facilities progessively growing our campus to include seven more factory buildings (2, 3, 5, 6, 7, 8 and 10).
A strategic leadership transition was implemented to support the organization’s next phase of global growth. Teruaki Itoh was appointed Chairman, and Yuichi Itoh assumed the role of President.
President Yuichi Itoh brings extensive operational experience, having held senior roles across manufacturing, engineering, operations, and business strategy. His appointment reinforces a manufacturing-driven philosophy and a continued commitment to consistent quality and technical excellence.
Pre-analytical Sample Preparation & Transport System
Benchtop Pre-analytical Sample Preparation System
Pre- & Post-analytical Sample Preparation & Transport System
Blood Collection Tube Labeling & Sorting Device
Blood Collection Tube Labeling Device
Pre-analytical Sample Preparation & Transport System
Pre-analytical Sample Preparation & Transport System
Stand-alone Aliquot System
Stand-alone Aliquot System
Integrated Aliquot System
Integrated Aliquot System
Sample Preparation & Transport System
Integrated Aliquot System
Lab Information System
Urine Aliquot System
Automatic Tube Labeler
Integrated Aliquot System
Beltless TLA
High to Ultra-High Volume TLA Prototype
Urine Aliquot System
Workcell to Total Laboratory Automation
From pioneering Japan’s early automation systems to delivering advanced open platforms for today’s laboratories.
Join us in shaping the future. As we continue to push the boundaries of innovation and excellence.
We value your privacy
We use cookies and similar technologies to ensure the proper functioning of our website, analyze usage, and, with your consent, support marketing and communication activities. By clicking “Accept All”, you consent to the use of all cookies. You can manage your preferences at any time via “Cookie Settings.”
Your Privacy Choices
When you visit our website, information may be stored or retrieved on your browser in the form of cookies. Some cookies are essential for the website to function properly, while others help us improve our services or support marketing activities. You can review and change your consent preferences at any time. Disabling certain categories may affect the availability or performance of some features.
Strictly Necessary Cookies
These cookies are essential for the operation and security of the website. They enable core functionalities such as page navigation, secure access, and system integrity. Without these cookies, the website cannot function properly.
Performance Cookies
These cookies help us understand how visitors interact with our website by collecting aggregated and anonymized information, such as page visits, traffic sources, and usage patterns. The insights gained allow us to improve website performance and usability.
Functional Cookies
Functional cookies allow the website to remember choices you make, such as language preferences or regional settings. They enable enhanced functionality and personalization but are not essential to the core operation of the website.
Targeting Cookies
These cookies may be set by us or by third-party partners to build a profile of your interests and show relevant content or communications on this and other websites. They do not store personal information directly but rely on uniquely identifying your browser or device.
Social Media Cookies
These cookies are set by social media platforms to enable content sharing and interaction features. They may track your browser across other websites and influence the content or messages you see on those platforms.
For more information about how we use cookies and process personal data, please review our Cookie Policy.
